Jagsonpal Pharmaceuticals Limited — Others, 28-07-2025: Copy of Newspaper Publication

Jagsonpal Pharmaceuticals Limited has released its unaudited financial results for the quarter ended June 30, 2025. The company reported a Total Income from Operations of 784.37, marking significant growth compared to 628.83 in the same quarter last year. Profit after tax also saw a strong rise, reaching 107.95 from 53.29 year-on-year. Basic Earnings per Share increased to 1.60 from 0.78 in the prior year's comparable quarter. These robust figures provide key insights into the company's operational strength and profitability for shareholders.